Details for New Drug Application (NDA): 022185
✉ Email this page to a colleague
The generic ingredient in TACLONEX is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
Summary for 022185
Tradename: | TACLONEX |
Applicant: | Leo Pharma As |
Ingredient: | betamethasone dipropionate; calcipotriene |
Patents: | 0 |
Pharmacology for NDA: 022185
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 022185
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185 | NDA | LEO Pharma Inc. | 50222-501 | 50222-501-06 | 40 CARTON in 1 CASE (50222-501-06) / 1 BOTTLE in 1 CARTON / 60 g in 1 BOTTLE |
TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185 | NDA | LEO Pharma Inc. | 50222-501 | 50222-501-66 | 10 PACKAGE in 1 BOX (50222-501-66) / 2 BOTTLE in 1 PACKAGE / 60 g in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;TOPICAL | Strength | 0.064%;0.005% | ||||
Approval Date: | May 9, 2008 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 022185
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185-001 | May 9, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185-001 | May 9, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Leo Pharma As | TACLONEX | betamethasone dipropionate; calcipotriene | SUSPENSION;TOPICAL | 022185-001 | May 9, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription